Visual Abstract for "A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease" (IMAGE)
Caption
The National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Diseases has released its final report, which outlines a new race-free approach to diagnose kidney disease. In the report jointly published in the American Journal of Kidney Diseases (AJKD) and the Journal of the American Society of Nephrology (JASN), the NKF-ASN Task Force recommends the adoption of the new eGFR 2021 CKD-EPI creatinine equation that estimates kidney function without a race variable. The task force also recommends increased use of cystatin C combined with serum (blood) creatinine, as a confirmatory assessment of GFR or kidney function. The new approach may report a different eGFR and could alter the stage of kidney diseases in some people. Patients should learn their latest eGFR and uACR to assess if the new eGFR calculations change their kidney disease status or stage. Patients and healthcare professionals can use a patient-friendly eGFR calculator that uses the new equation to determine a non-race-based calculation to assess their kidney function. It is important for patients to speak with their doctors to determine if this may affect their treatment and care going forward.
Credit
Visual Graphic by Edgar Lerma, MD, FASN
Usage Restrictions
Please cite as "Visual Abstract for 'A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease' (AJKD and JASN, 2021)"
License
Licensed content